$134.98
-0.83-0.61%
À la fermeture: -
$134.86
-0.12-0.09%
Après les heures de négociation: Oct 24, 7:33 PM EDT
Comments
Loading...
Évaluations des analystes, objectifs de prix, prévision
Phillips 66 a un objectif de cours consensus de $145.62, basé sur les évaluations des 22 analystes. Le plus élevé est de $180 attribué par B of A Securities le mars 15, 2024, et le plus bas est de $122 attribué par Morgan Stanley le avril 24, 2025. Les 3 dernières évaluations d'analystes ont été publiées par Raymond James, Wells Fargo et Jefferies le octobre 17, 2025, octobre 17, 2025 et octobre 10, 2025. Avec un objectif de cours moyen de $147 entre Raymond James, Wells Fargo et Jefferies, il y a une variation implicite de 9.00% upside pour Phillips 66 à partir de ces dernières évaluations d'analystes.
Sociétés d'analyse émettant des recommandations1
Raymond James
Wells Fargo
Jefferies
Barclays
Morgan Stanley
1calculé à partir des notes des analystes
Notes d'analystes pour Phillips 66
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
10/17/2025 | 11.23% | Raymond James | $145 → $150 | Reiterates | Outperform → Outperform | |||
10/17/2025 | 14.19% | Wells Fargo | → $154 | Initiates | → Overweight | |||
10/10/2025 | 1.59% | Jefferies | $133 → $137 | Maintains | Hold | |||
10/07/2025 | -2.12% | Barclays | $127 → $132 | Maintains | Equal-Weight | |||
10/03/2025 | 3.81% | Morgan Stanley | $128 → $140 | Maintains | Equal-Weight | |||
09/29/2025 | 14.93% | Piper Sandler | $154 → $155 | Maintains | Neutral | |||
09/22/2025 | 11.23% | UBS | $143 → $150 | Maintains | Buy | |||
09/19/2025 | 26.06% | Evercore ISI Group | $130 → $170 | Maintains | Outperform | |||
09/15/2025 | 5.29% | Mizuho | $140 → $142 | Maintains | Neutral | |||
09/11/2025 | 14.19% | Piper Sandler | $144 → $154 | Maintains | Neutral | |||
09/09/2025 | 7.52% | Raymond James | $142 → $145 | Maintains | Outperform | |||
09/03/2025 | 9% | B of A Securities | $144 → $147 | Downgrade | Buy → Neutral | |||
08/04/2025 | 7.52% | Piper Sandler | $144 → $145 | Maintains | Neutral | |||
07/28/2025 | 6.04% | UBS | $141 → $143 | Maintains | Buy | |||
07/28/2025 | 6.78% | Piper Sandler | $147 → $144 | Maintains | Neutral | |||
07/22/2025 | 9% | Piper Sandler | $148 → $147 | Maintains | Neutral | |||
07/16/2025 | -5.09% | Morgan Stanley | $122 → $128 | Maintains | Equal-Weight | |||
07/16/2025 | -3.6% | Citigroup | $126 → $130 | Downgrade | Buy → Neutral | |||
07/15/2025 | 5.29% | Raymond James | $135 → $142 | Maintains | Outperform | |||
07/11/2025 | -1.38% | Scotiabank | → $133 | Downgrade | Sector Outperform → Sector Perform | |||
07/10/2025 | 9.74% | Piper Sandler | $131 → $148 | Maintains | Neutral | |||
07/09/2025 | -5.83% | Barclays | $115 → $127 | Maintains | Equal-Weight | |||
06/18/2025 | -3.6% | Evercore ISI Group | → $130 | Initiates | → Outperform | |||
06/11/2025 | 9% | Wells Fargo | $149 → $147 | Maintains | Overweight | |||
05/13/2025 | 2.33% | Mizuho | $132 → $138 | Maintains | Neutral | |||
05/12/2025 | -14.73% | Barclays | $106 → $115 | Maintains | Equal-Weight | |||
04/29/2025 | -2.86% | JP Morgan | $138 → $131 | Maintains | Overweight | |||
04/28/2025 | 3.81% | UBS | $144 → $140 | Maintains | Buy | |||
04/28/2025 | 10.48% | Wells Fargo | $162 → $149 | Maintains | Overweight | |||
04/24/2025 | -9.54% | Morgan Stanley | $140 → $122 | Maintains | Equal-Weight | |||
04/11/2025 | -1.38% | Scotiabank | $136 → $133 | Maintains | Sector Outperform | |||
04/10/2025 | -21.4% | Barclays | $135 → $106 | Maintains | Equal-Weight | |||
04/09/2025 | 3.81% | Raymond James | $150 → $140 | Maintains | Outperform | |||
04/09/2025 | -2.12% | Mizuho | $140 → $132 | Maintains | Neutral | |||
03/27/2025 | -2.12% | Goldman Sachs | $132 → $132 | Downgrade | Buy → Neutral | |||
03/14/2025 | 0.1% | Barclays | $115 → $135 | Maintains | Equal-Weight | |||
02/03/2025 | 20.12% | Wells Fargo | $161 → $162 | Maintains | Overweight | |||
01/13/2025 | -14.73% | Barclays | $124 → $115 | Maintains | Equal-Weight | |||
01/03/2025 | — | Wolfe Research | — | Upgrade | Peer Perform → Outperform | |||
12/16/2024 | 9% | Mizuho | $150 → $147 | Maintains | Neutral | |||
12/10/2024 | 3.81% | JP Morgan | $141 → $140 | Maintains | Overweight | |||
12/09/2024 | 19.38% | Wells Fargo | $167 → $161 | Maintains | Overweight | |||
11/11/2024 | -8.05% | Barclays | $133 → $124 | Maintains | Equal-Weight | |||
11/04/2024 | 2.33% | UBS | $150 → $138 | Maintains | Buy | |||
10/17/2024 | 15.68% | B of A Securities | → $156 | Reinstates | → Buy | |||
10/10/2024 | 0.85% | Scotiabank | $145 → $136 | Maintains | Sector Outperform | |||
10/09/2024 | 23.83% | Wells Fargo | $182 → $167 | Maintains | Overweight | |||
10/08/2024 | -1.38% | Barclays | $138 → $133 | Maintains | Equal-Weight | |||
10/08/2024 | 6.78% | Piper Sandler | $136 → $144 | Maintains | Overweight | |||
10/02/2024 | 4.55% | JP Morgan | $160 → $141 | Maintains | Overweight | |||
09/20/2024 | 0.85% | Piper Sandler | $151 → $136 | Maintains | Overweight | |||
09/16/2024 | 6.78% | Morgan Stanley | $150 → $144 | Maintains | Equal-Weight | |||
09/16/2024 | 11.23% | Mizuho | $154 → $150 | Maintains | Neutral | |||
09/11/2024 | 11.23% | TD Cowen | $162 → $150 | Maintains | Buy | |||
09/03/2024 | 34.95% | Wells Fargo | $176 → $182 | Maintains | Overweight | |||
08/05/2024 | 2.33% | Barclays | $136 → $138 | Maintains | Equal-Weight | |||
07/31/2024 | 20.12% | TD Cowen | $155 → $162 | Maintains | Buy | |||
07/31/2024 | 14.93% | Raymond James | $150 → $155 | Maintains | Outperform | |||
07/31/2024 | 30.51% | Wells Fargo | $180 → $176 | Maintains | Overweight | |||
07/18/2024 | — | Wolfe Research | — | Reinstates | → Peer Perform | |||
07/12/2024 | 7.52% | Scotiabank | $156 → $145 | Maintains | Sector Outperform | |||
07/09/2024 | 0.85% | Barclays | $142 → $136 | Maintains | Equal-Weight | |||
07/02/2024 | 20.12% | JP Morgan | $165 → $162 | Maintains | Overweight | |||
07/01/2024 | 5.29% | Barclays | $147 → $142 | Maintains | Equal-Weight | |||
06/21/2024 | 14.93% | TD Cowen | $164 → $155 | Maintains | Buy | |||
06/20/2024 | 18.64% | Mizuho | $162 → $160 | Maintains | Neutral | |||
06/14/2024 | 11.97% | Piper Sandler | $170 → $151 | Maintains | Overweight | |||
05/30/2024 | 23.83% | Argus Research | $167 → $167 | Reiterates | Buy → Buy | |||
05/30/2024 | 18.64% | Raymond James | $163 → $160 | Maintains | Outperform | |||
05/14/2024 | 26.06% | Piper Sandler | $187 → $170 | Maintains | Overweight | |||
04/30/2024 | 9% | Barclays | $155 → $147 | Maintains | Equal-Weight | |||
04/18/2024 | 14.93% | Barclays | $139 → $155 | Maintains | Equal-Weight | |||
04/12/2024 | 20.12% | Mizuho | $167 → $162 | Maintains | Neutral | |||
04/11/2024 | 15.68% | Scotiabank | $148 → $156 | Maintains | Sector Outperform | |||
04/08/2024 | 41.63% | Wells Fargo | $179 → $191 | Maintains | Overweight | |||
04/05/2024 | 38.66% | Piper Sandler | $169 → $187 | Maintains | Overweight | |||
04/01/2024 | 23.83% | JP Morgan | $149 → $167 | Maintains | Overweight | |||
03/22/2024 | 29.02% | Goldman Sachs | $152 → $174 | Maintains | Buy | |||
03/22/2024 | 23.83% | Mizuho | $135 → $167 | Maintains | Neutral | |||
03/20/2024 | 32.73% | Wells Fargo | $163 → $179 | Maintains | Overweight | |||
03/15/2024 | 33.47% | B of A Securities | $150 → $180 | Maintains | Neutral | |||
03/08/2024 | 25.32% | Piper Sandler | $165 → $169 | Maintains | Overweight | |||
02/05/2024 | 3.07% | Barclays | $132 → $139 | Maintains | Equal-Weight | |||
02/01/2024 | 20.87% | Wells Fargo | $151 → $163 | Maintains | Overweight | |||
02/01/2024 | 14.93% | Raymond James | $140 → $155 | Maintains | Outperform | |||
12/19/2023 | 3.81% | Raymond James | $128 → $140 | Maintains | Outperform | |||
12/04/2023 | 11.23% | TD Cowen | $134 → $150 | Maintains | Outperform | |||
10/31/2023 | 8.26% | Wolfe Research | → $146 | Upgrade | Peer Perform → Outperform | |||
10/06/2023 | -13.98% | Mizuho | $131 → $116 | Maintains | Neutral | |||
10/06/2023 | -5.09% | Raymond James | $133 → $128 | Maintains | Outperform | |||
10/05/2023 | -0.64% | Piper Sandler | $138 → $134 | Maintains | Overweight | |||
09/20/2023 | -1.38% | Raymond James | $125 → $133 | Maintains | Outperform | |||
09/18/2023 | 6.04% | B of A Securities | $141 → $143 | Maintains | Neutral | |||
09/18/2023 | -2.86% | Mizuho | $127 → $131 | Maintains | Neutral | |||
09/08/2023 | 6.78% | Wells Fargo | $130 → $144 | Maintains | Overweight | |||
09/01/2023 | 4.55% | Goldman Sachs | $125 → $141 | Maintains | Buy | |||
08/16/2023 | -5.83% | Mizuho | $118 → $127 | Maintains | Neutral | |||
08/14/2023 | -0.64% | Argus Research | $125 → $134 | Maintains | Buy | |||
08/03/2023 | -3.6% | Wells Fargo | $111 → $130 | Maintains | Overweight | |||
07/19/2023 | -7.31% | Morgan Stanley | $125 → $125 | Reiterates | Equal-Weight → Equal-Weight |
FAQ
Quel est le cours indicatif de l'action Phillips 66 (PSX) ?
Le dernier objectif de prix pour Phillips 66 (NYSE:PSX) a été rapporté par Raymond James le octobre 17, 2025. Le cabinet d'analystes a fixé un objectif de prix pour $150.00 s'attendant à ce que PSX se rise dans les 12 prochains mois (un possible changement de 11.23% upside). 44 cabinets d'analystes ont rapporté des notes au cours de la dernière année.
Quelle est la note d'analyste la plus récente pour Phillips 66 (PSX) ?
La dernière note d'analyste pour Phillips 66 (NYSE:PSX) a été fournie par Raymond James, et Phillips 66 réitéré leur note outperform.
Quand a eu lieu la dernière mise à niveau pour Phillips 66 (PSX) ?
La dernière amélioration pour Phillips 66 a eu lieu le janvier 3, 2025 lorsque Wolfe Research a augmenté leur objectif de prix à N/A. Wolfe Research avait précédemment a peer perform pour Phillips 66.
Quand a eu lieu la dernière dégradation pour Phillips 66 (PSX) ?
La dernière réduction pour Phillips 66 a eu lieu le septembre 3, 2025 lorsque B of A Securities a changé leur objectif de prix de $144 à $147 pour Phillips 66.
Quand la prochaine note d'analyste sera-t-elle publiée ou mise à jour pour Phillips 66 (PSX) ?
Les analystes arrivent à des évaluations d'actions après avoir effectué des recherches approfondies, ce qui inclut l'examen des états financiers publics, la discussion avec les dirigeants et les clients de Phillips 66, et l'écoute des conférences téléphoniques sur les résultats. La plupart des analystes font cela tous les trois mois, vous devriez donc obtenir 4 notes par entreprise par société chaque année. La dernière note pour Phillips 66 a été déposée le octobre 17, 2025, donc vous devriez vous attendre à ce que la prochaine note soit disponible vers octobre 17, 2026.
La note d'analyste pour Phillips 66 (PSX) est-elle correcte ?
Bien que les évaluations soient subjectives et changeront, la dernière note de Phillips 66 (PSX) était un réitéré avec un objectif de prix de $145.00 à $150.00. Le prix actuel de Phillips 66 (PSX) est de $134.86, ce qui est out of la fourchette prédite par l'analyste.
Parcourir notes d'analystes et objectifs de cours sur toutes les actions.